These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 4080962)
41. [Clinical applications of the carcinoembryonic antigen (CEA) determination in colorectal cancer (observations of 119 cases)]. Sivelli R; Farinon AM; Chiampo L Chir Ital; 1980 Oct; 32(5):946-63. PubMed ID: 6166402 [TBL] [Abstract][Full Text] [Related]
42. A rational postoperative follow-up with carcinoembryonic antigen, tissue polypeptide antigen, and urinary hydroxyproline in breast cancer patients. Nicolini A; Carpi A; Di Marco G; Giuliani L; Giordani R; Palla S Cancer; 1989 May; 63(10):2037-46. PubMed ID: 2702573 [TBL] [Abstract][Full Text] [Related]
43. Serum levels of carcinoembryonic antigen and a tumor-extracted carcinoembryonic antigen-related antigen in cancer patients. Shively JE; Spayth V; Chang FF; Metter GE; Klein L; Presant CA; Todd CW Cancer Res; 1982 Jun; 42(6):2506-13. PubMed ID: 7074626 [TBL] [Abstract][Full Text] [Related]
44. Comparative evaluation of four tumor markers, CA 242, CA 19/9, TPA and CEA in carcinomas of the colon. von Kleist S; Hesse Y; Kananeeh H Anticancer Res; 1996; 16(4B):2325-31. PubMed ID: 8694564 [TBL] [Abstract][Full Text] [Related]
45. Evaluation of neuron-specific enolase, tissue polypeptide antigen, and carcinoembryonic antigen as markers for staging and monitoring response to therapy of lung cancer. Spinazzi A; Soresi E; Boffi R; Nonis A; Noseda A; Cobelli S; Scanni A Cancer Detect Prev; 1994; 18(3):209-20. PubMed ID: 8076383 [TBL] [Abstract][Full Text] [Related]
46. [Correlation of carcinoembryonic antigen (CEA) and serum and tissue alpha-fetoprotein (AFP) in malignant tumors of the female genital tract]. Tolino A; Di Serio C; Borruto Caracciolo G; Giamberini S; Montemagno U G Ital Oncol; 1989; 9(2-3):63-6. PubMed ID: 2475441 [TBL] [Abstract][Full Text] [Related]
48. Clinical evaluation of tissue polypeptide antigen (TPA) in the diagnosis of pancreatic carcinoma. Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttila I Anticancer Res; 1993; 13(5C):1883-7. PubMed ID: 8267397 [TBL] [Abstract][Full Text] [Related]
49. Detection of gastric cancer by a combination of tissue polypeptide antigen (TPA), lipid-bound sialic acid (LBSA) and carcinoembryonic antigen (CEA). Uehara Y; Kojima O; Ikeda E; Majima T; Nishioka B; Fujita Y; Majima S Gastroenterol Jpn; 1984 Oct; 19(5):424-9. PubMed ID: 6519414 [TBL] [Abstract][Full Text] [Related]
50. Monitoring different stages of breast cancer using tumour markers CA 15-3, CEA and TPA. Sölétormos G; Nielsen D; Schiøler V; Mouridsen H; Dombernowsky P Eur J Cancer; 2004 Mar; 40(4):481-6. PubMed ID: 14962712 [TBL] [Abstract][Full Text] [Related]
51. [CEA and TPA in serum and pleural exudates in patients with pulmonary neoplasms: preliminary results]. Iannucci F; di Matteo L; Di Martino G; Tranchese D; Auriemma L; Micillo E; Catena E Arch Monaldi; 1983; 38(1-2):3-8. PubMed ID: 6675556 [No Abstract] [Full Text] [Related]
52. Determination of tissue polypeptide antigens (TPA) and carcinoembryonic antigen (CEA) in serum: its value in the preliminary cancer risk assessment in asbestos exposed workers. Lutz W; Krajewska B; Piłacik B Int J Occup Med Environ Health; 1997; 10(3):259-65. PubMed ID: 9524403 [TBL] [Abstract][Full Text] [Related]
53. [Association of serum tumor markers in solid neoplasms (CEA, ferritin, alpha 1-antitrypsin, parathormone and calcitonin)]. Di Martino G; Iannucci F; Bizzarro A; Iacono G Boll Ist Sieroter Milan; 1982; 61(5):411-22. PubMed ID: 6985416 [TBL] [Abstract][Full Text] [Related]
54. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix. Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449 [TBL] [Abstract][Full Text] [Related]
55. Significance of tumour markers in nasopharyngeal carcinoma. Kuo WR; Tsai SM; Jong SB; Juan KH J Otolaryngol; 1996 Feb; 25(1):32-6. PubMed ID: 8816107 [TBL] [Abstract][Full Text] [Related]
56. [Does an obturation in colorectal cancer also modify the behavior of the serum CEA level?]. Wedell J; Meyer zu Eissen P; Muchow U; van Calker H; Baginski B; Schlipköter HW Zentralbl Chir; 1983; 108(15):967-73. PubMed ID: 6637204 [TBL] [Abstract][Full Text] [Related]
57. [Clinical significance of serum tumor markers (CEA, TPA, IAP and ferritin) in pulmonary tuberculosis]. Komatsu H Kekkaku; 1987 Jan; 62(1):31-6. PubMed ID: 3573509 [No Abstract] [Full Text] [Related]
58. [Tissue polypeptide antigen (TPA) as a tumor marker in disorders of the digestive tract: comparison with CEA]. Piantino P; Tappero G; Cerchier A; Pecchio F; Tridico F; Cattaneo U Minerva Med; 1986 Apr; 77(16):617-20. PubMed ID: 3703360 [TBL] [Abstract][Full Text] [Related]
59. Clinical significance of carcinoembryonic antigen (CEA) in patients with adenocarcinoma in colon and rectum. Lunde OC; Havig O Acta Chir Scand; 1982; 148(2):189-93. PubMed ID: 7148317 [TBL] [Abstract][Full Text] [Related]
60. Carcinoembryonic antigen radioimmunodetection in the evaluation of colorectal cancer and in the detection of occult neoplasms. Goldenberg DM; Kim EE; Bennett SJ; Nelson MO; Deland FH Gastroenterology; 1983 Mar; 84(3):524-32. PubMed ID: 6295871 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]